Weiss Ratings Reiterates Sell (E+) Rating for P3 Health Partners (NASDAQ:PIII)

Key Points

• Weiss Ratings has reaffirmed a "sell (E+)" rating for P3 Health Partners (NASDAQ:PIII), indicating continued skepticism about the company's stock performance.
• Despite the negative rating from Weiss, Lake Street Capital has initiated coverage with a "buy" rating and a price target of $20.00.
• P3 Health Partners reported a quarterly earnings miss with an EPS of ($6.23), significantly below the consensus estimate of ($3.29).

P3 Health Partners (NASDAQ:PIII - Get Free Report)'s stock had its "sell (e+)" rating reaffirmed by research analysts at Weiss Ratings in a report issued on Saturday,Weiss Ratings reports.

Separately, Lake Street Capital began coverage on P3 Health Partners in a research report on Thursday, August 28th. They issued a "buy" rating and a $20.00 price objective for the company. One research analyst has rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Hold" and a consensus price target of $16.25.

P3 Health Partners Price Performance

Shares of PIII opened at $8.84 on Friday. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.31 and a current ratio of 0.31. The stock has a 50 day simple moving average of $8.57 and a 200 day simple moving average of $7.78. P3 Health Partners has a 52-week low of $5.80 and a 52-week high of $22.64. The firm has a market capitalization of $63.56 million, a PE ratio of -0.19 and a beta of 0.84.

P3 Health Partners (NASDAQ:PIII - Get Free Report) last issued its quarterly earnings data on Thursday, August 14th. The company reported ($6.23) earnings per share (EPS) for the quarter, missing the consensus estimate of ($3.29) by ($2.94). P3 Health Partners had a negative net margin of 9.99% and a negative return on equity of 183.60%. The business had revenue of $355.79 million during the quarter, compared to analyst estimates of $356.52 million. P3 Health Partners has set its FY 2025 guidance at EPS. Sell-side analysts predict that P3 Health Partners will post -0.67 EPS for the current fiscal year.

Institutional Investors Weigh In On P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC raised its position in P3 Health Partners Inc. (NASDAQ:PIII - Free Report) by 4.6% during the 3rd quarter, according to its most recent filing with the SEC. The institutional investor owned 26,678 shares of the company's stock after acquiring an additional 1,178 shares during the period. Trinity Financial Advisors LLC owned about 0.37% of P3 Health Partners worth $239,000 as of its most recent filing with the SEC. Institutional investors own 7.75% of the company's stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.